High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma.
Long GD, Chao NJ, Hu WW, Negrin RS, Wong RM, Blume KG.
Long GD, et al.
Cancer. 1996 Dec 15;78(12):2502-9. doi: 10.1002/(sici)1097-0142(19961215)78:12<2502::aid-cncr9>3.0.co;2-l.
Cancer. 1996.
PMID: 8952558
Blood progenitor cells were collected after treatment with cyclophosphamide at a dose of 4 g/m2 followed by granulocyte-colony stimulating factor (G-CSF) at a dose of approximately 10 micrograms/kg/day subcutaneously, and the collection continued daily until the tar …
Blood progenitor cells were collected after treatment with cyclophosphamide at a dose of 4 g/m2 followed by granulocyte-colony stimul …